Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chien-Hsing Chang

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphyThomas M Cardillo, Habibe Karacay, David M Goldenberg, et al.
Molecular Cancer Therapeutics|October 29, 2017
Selective and Concentrated Accretion of SN-38 with a CEACAM5-Targeting Antibody-Drug Conjugate (ADC), Labetuzumab Govitecan (IMMU-130)Robert M Sharkey, Serengulam V Govindan, Thomas M Cardillo, et al.
Plos One|July 31, 2012
A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitroChien-Hsing Chang, Jorma Hinkula, Meiyu Loo, et al.
Radiology|January 30, 2008
Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse modelRobert M Sharkey, Habibe Karacay, Shankar Vallabhajosula, et al.
Blood|January 25, 2012
Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomasPankaj Gupta, David M Goldenberg, Edmund A Rossi, et al.
Oncotarget|November 16, 2020
Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancerThomas M Cardillo, Diane L Rossi, Maria B Zalath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methodsRobert M Sharkey, Habibe Karacay, Thomas M Cardillo, et al.
Methods (San Diego, Calif.)|April 26, 2005
Development of humanized antibodies as cancer therapeuticsZhengxing Qu, Gary L Griffiths, William A Wegener, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 3, 2005
Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibodyEric Mirallié, Catherine Saï-Maurel, Alain Faivre-Chauvet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2009
Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabineHabibe Karacay, Robert M Sharkey, David V Gold, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphyThomas M Cardillo, Habibe Karacay, David M Goldenberg, et al.
Molecular Cancer Therapeutics|October 29, 2017
Selective and Concentrated Accretion of SN-38 with a CEACAM5-Targeting Antibody-Drug Conjugate (ADC), Labetuzumab Govitecan (IMMU-130)Robert M Sharkey, Serengulam V Govindan, Thomas M Cardillo, et al.
Plos One|July 31, 2012
A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitroChien-Hsing Chang, Jorma Hinkula, Meiyu Loo, et al.
Radiology|January 30, 2008
Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse modelRobert M Sharkey, Habibe Karacay, Shankar Vallabhajosula, et al.
Blood|January 25, 2012
Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomasPankaj Gupta, David M Goldenberg, Edmund A Rossi, et al.
Oncotarget|November 16, 2020
Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancerThomas M Cardillo, Diane L Rossi, Maria B Zalath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methodsRobert M Sharkey, Habibe Karacay, Thomas M Cardillo, et al.
Methods (San Diego, Calif.)|April 26, 2005
Development of humanized antibodies as cancer therapeuticsZhengxing Qu, Gary L Griffiths, William A Wegener, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 3, 2005
Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibodyEric Mirallié, Catherine Saï-Maurel, Alain Faivre-Chauvet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2009
Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabineHabibe Karacay, Robert M Sharkey, David V Gold, et al.
Pageof 10